Healthcare reform is already presenting new challenges and opportunities for endocrinology, a specialty that is under significant stress in the United States. A critical workforce shortage has drained the pool of practicing endocrinologists, just as the Affordable Care Act (ACA) is expected to send millions of newly insured people into the system.
Healthcare reform is already presenting new challenges and opportunities for endocrinology, a specialty that is under significant stress in the United States. A critical workforce shortage has drained the pool of practicing endocrinologists, just as the Affordable Care Act (ACA) is expected to send millions of newly insured people into the system.
If patients need specialty endocrine care, some experts predict that they will face lengthy waits. "Patients may be able to gain access to an insurance card, but not necessarily access to a physician," says Jonathan D. Leffert, MD, an endocrinologist in private practice in Dallas, Texas, and secretary of the American Association of Clinical Endocrinologist.
At the same time, the Center for Medicare & Medicaid Innovation of the Centers for Medicare & Medicaid Services (CMS), which was created by the ACA, is testing promising new methods of healthcare delivery.Endocrinologists involved in these experiments, which include Accountable Care Organizations (ACOs) and patient-centered medical neighborhoods (PCMNs), report that these new models -- which aim to boost care coordination, lower costs, and improve access -- are tailor-made for endocrinology, a specialty that must maximize its resources.
Read the full story here: http://bit.ly/1dP6tCT
Source: Medscape
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More